Which has higher access to anti-retroviral drugs, female, Afghanistan or Syrian Arab Republic?

Syrian Arab Republic, at 41.0% against 38.0% in Afghanistan as of 2024.

What is the difference in access to anti-retroviral drugs, female between Afghanistan and Syrian Arab Republic?

3.0%, with Syrian Arab Republic ahead.

How many years of comparable data are there for Afghanistan and Syrian Arab Republic?

25 years are reported by both, from 2000 to 2024.

Where does this data come from?

UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Afghanistan vs Syrian Arab Republic: Access to anti-retroviral drugs, female

Afghanistan

38.0%

in 2024

Syrian Arab Republic

41.0%

in 2024

Afghanistan rank

129th

Syrian Arab Republic rank

127th

Access to anti-retroviral drugs, female over time

Afghanistan
Syrian Arab Republic

How they compare

Syrian Arab Republic currently reports 41.0% against 38.0% in Afghanistan, a difference of 3.0%.

That makes Syrian Arab Republic's figure about 1.1 times Afghanistan's.

The two have swapped places 2 times across 25 shared years of data; in 2000 it was Syrian Arab Republic ahead.

Afghanistan ranks 129th and Syrian Arab Republic ranks 127th of 141 countries.

Syrian Arab Republic has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade	Afghanistan	Syrian Arab Republic	Difference	Ahead
2000s	0.1%	5.4%	5.3%	Syrian Arab Republic
2010s	17.6%	26.9%	9.3%	Syrian Arab Republic
2020s	33.8%	41.4%	7.6%	Syrian Arab Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Afghanistan or Syrian Arab Republic?: Syrian Arab Republic, at 41.0% against 38.0% in Afghanistan as of 2024.
What is the difference in access to anti-retroviral drugs, female between Afghanistan and Syrian Arab Republic?: 3.0%, with Syrian Arab Republic ahead.
How many years of comparable data are there for Afghanistan and Syrian Arab Republic?: 25 years are reported by both, from 2000 to 2024.
How do Afghanistan and Syrian Arab Republic rank globally for access to anti-retroviral drugs, female?: Afghanistan ranks 129th and Syrian Arab Republic ranks 127th of 141 countries.
Where does this data come from?: UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Afghanistan vs Syrian Arab Republic: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 17 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/afghanistan/syrian-arab-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/afghanistan/syrian-arab-republic/">Afghanistan vs Syrian Arab Republic: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator: Access to anti-retroviral drugs, female (%)
Unit: %
Source: UNAIDS estimates
Licence: CC BY 4.0 (World Bank Open Data)
Coverage: 160 places, 3,925 data points, 2000–2024
Last refreshed: 04 September 2026

The percentage of adult females living with HIV who are receiving antiretroviral therapy.